MARKOVIC, UROS
 Distribuzione geografica
Continente #
NA - Nord America 156
EU - Europa 138
AF - Africa 64
AS - Asia 13
OC - Oceania 1
Totale 372
Nazione #
US - Stati Uniti d'America 151
IT - Italia 60
IE - Irlanda 50
CI - Costa d'Avorio 41
SN - Senegal 19
BE - Belgio 15
CN - Cina 8
CA - Canada 5
DE - Germania 4
IN - India 4
NG - Nigeria 4
FR - Francia 2
RU - Federazione Russa 2
AU - Australia 1
CH - Svizzera 1
GB - Regno Unito 1
GR - Grecia 1
LK - Sri Lanka 1
SE - Svezia 1
UA - Ucraina 1
Totale 372
Città #
Dublin 50
Abidjan 41
Chandler 35
Dakar 19
Ashburn 17
Brussels 15
Rome 12
Cambridge 9
Lawrence 9
Catania 7
Andover 6
Abuja 4
Des Moines 4
Milan 4
Jacksonville 3
Los Angeles 3
Naples 3
San Francisco 3
Washington 3
Assago 2
Bremen 2
Godhra 2
Mascalucia 2
Nanaimo 2
Norwalk 2
Palermo 2
Pedara 2
Redwood City 2
Trecastagni 2
Turin 2
Wilmington 2
Beijing 1
Boardman 1
Colombo 1
Cornate D'adda 1
Cosenza 1
Cuneo 1
Fairfield 1
Florence 1
Fort St. James 1
Frankfurt Am Main 1
Hanover 1
Marino 1
Markham 1
Melbourne 1
Pavia 1
Perpignan 1
Saint Petersburg 1
Toronto 1
Torre A Mare 1
Totale 290
Nome #
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 45
Serum free light chains and multiple myeloma: Is it time to extend their application? 30
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study 29
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 28
VEXAS-like syndrome: a potential new entity? 28
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients 27
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 26
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 23
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study 21
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 21
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 20
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 19
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 19
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 18
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 17
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 14
Multiple Myeloma in 2023 Ways: From Trials to Real Life 10
Totale 395
Categoria #
all - tutte 2.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 1 1 1
2020/202110 0 0 2 1 1 1 3 0 0 0 2 0
2021/202262 5 7 1 1 7 2 9 2 4 3 0 21
2022/2023185 10 11 6 8 16 24 1 34 47 0 22 6
2023/2024135 9 40 6 9 5 39 7 16 0 3 1 0
Totale 395